CoChat

Metabolic Adaptations During Staphylococcus aureus and Candida albicans Co-Infection

Eichelberger, Kara R., Cassat, James E. · 2021 · Frontiers in Immunology
Cited by 67

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Successful pathogens require metabolic flexibility to adapt to diverse host niches. The presence of co-infecting or commensal microorganisms at a given infection site can further influence the metabolic processes required for a pathogen to cause disease. The Gram-positive bacterium Staphylococcus aureus and the polymorphic fungus Candida albicans are microorganisms that asymptomatically colonize healthy individuals but can also cause superficial infections or severe invasive disease. Due to many shared host niches, S. aureus and C. albicans are frequently co-isolated from mixed fungal-bacterial infections. S. aureus and C. albicans co-infection alters microbial metabolism relative to infection with either organism alone. Metabolic changes during co-infection regulate virulence, such as enhancing toxin production in S. aureus or contributing to morphogenesis and cell wall remodeling in C. albicans. C. albicans and S. aureus also form polymicrobial biofilms, which have greater biomass and reduced susceptibility to antimicrobials relative to mono-microbial biofilms. The S. aureus and C. albicans metabolic programs induced during co-infection impact interactions with host immune cells, resulting in greater microbial survival and immune evasion. Conversely, innate immune cell sensing of S. aureus and C. albicans triggers metabolic changes in the host cells that result in an altered immune response to secondary infections. In this review article, we discuss the metabolic programs that govern host-pathogen interactions during S. aureus and C. albicans co-infection. Understanding C. albicans-S. aureus interactions may highlight more general principles of how polymicrobial interactions, particularly fungal-bacterial interactions, shape the outcome of infectious disease. We focus on how co-infection alters microbial metabolism to enhance virulence and how infection-induced changes to host cell metabolism can impact a secondary infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2021.797550

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 112

  1. Brogden, 2005, Human Polymicrobial Infections, Lancet, 365, 10.1016/S0140-6736(05)70155-0 · DOI · Paper page
  2. Dyess, 1985, Candida Sepsis: Implications of Polymicrobial Blood-Borne Infection, Arch Surg-chicago, 120, 10.1001/archsurg.1985.01390270083014 · DOI · Paper page
  3. Rolston, 2007, Polymicrobial Infection in Patients With Cancer: An Underappreciated and Underreported Entity, Clin Infect Dis, 45, 10.1086/518873 · DOI · Paper page
  4. Carolus, 2019, Candida albicans and Staphylococcus Species: A Threatening Twosome, Front Microbiol, 10, 10.3389/fmicb.2019.02162 · DOI · Paper page
  5. Peters, 2012, Polymicrobial Interactions: Impact on Pathogenesis and Human Disease, Clin Microbiol Rev, 25, 193, 10.1128/CMR.00013-11 · DOI · Paper page
  6. Short, 2014, Polybacterial Human Disease: The Ills of Social Networking, Trends Microbiol, 22, 10.1016/j.tim.2014.05.007 · DOI · Paper page
  7. Tay, 2016, Polymicrobial–Host Interactions During Infection, J Mol Biol, 428, 10.1016/j.jmb.2016.05.006 · DOI
  8. Klotz, 2007, Polymicrobial Bloodstream Infections Involving Candida Species: Analysis of Patients and Review of the Literature, Diagn Micr Infect Dis, 59, 10.1016/j.diagmicrobio.2007.07.001 · DOI · Paper page
  9. Shirtliff, 2009, Cross-Kingdom Interactions: Candida albicans and Bacteria, FEMS Microbiol Lett, 299, 1, 10.1111/j.1574-6968.2009.01668.x · DOI · Paper page
  10. Douglas, 2003, Candida Biofilms and Their Role in Infection, Trends Microbiol, 11, 10.1016/S0966-842X(02)00002-1 · DOI · Paper page
  11. Krismer, 2017, The Commensal Lifestyle of Staphylococcus aureus and Its Interactions With the Nasal Microbiota, Nat Rev Microbiol, 15, 10.1038/nrmicro.2017.104 · DOI · Paper page
  12. Miramón, 2017, A Feast for Candida: Metabolic Plasticity Confers an Edge for Virulence, PLoS Pathog, 13, e1006144, 10.1371/journal.ppat.1006144 · DOI · Paper page
  13. Horn, 2021, Crosstalk Between Staphylococcus aureus and Innate Immunity: Focus on Immunometabolism, Front Immunol, 11, 10.3389/fimmu.2020.621750 · DOI · Paper page
  14. Peters, 2014, Fungal Morphogenetic Pathways Are Required for the Hallmark Inflammatory Response During Candida albicans Vaginitis, Infect Immun, 82, 10.1128/IAI.01417-13 · DOI · Paper page
  15. Dunker, 2021, Rapid Proliferation Due to Better Metabolic Adaptation Results in Full Virulence of a Filament-Deficient Candida albicans Strain, Nat Commun, 12, 3899, 10.1038/s41467-021-24095-8 · DOI · Paper page
  16. Balasubramanian, 2017, Staphylococcus aureus Pathogenesis in Diverse Host Environments, Pathog Dis, 75, ftx005, 10.1093/femspd/ftx005 · DOI · Paper page
  17. de Jong, 2019, Immune Evasion by Staphylococcus aureus, Microbiol Spectr, 7, 10.1128/microbiolspec.GPP3-0061-2019 · DOI · Paper page
  18. Tam, 2019, Staphylococcus aureus Secreted Toxins and Extracellular Enzymes, Microbiol Spectr, 7, 10.1128/microbiolspec.GPP3-0039-2018 · DOI · Paper page
  19. Butrico, 2020, Quorum Sensing and Toxin Production in Staphylococcus aureus Osteomyelitis: Pathogenesis and Paradox, Toxins, 12, 516, 10.3390/toxins12080516 · DOI · Paper page
  20. Carlson, 1982, Synergistic Effect of Candida albicans and Staphylococcus aureus on Mouse Mortality, Infect Immun, 38, 10.1128/iai.38.3.921-924.1982 · DOI · Paper page
  21. Carlson, 1983, Effect of Strain of Staphylococcus aureus on Synergism With Candida albicans Resulting in Mouse Mortality and Morbidity, Infect Immun, 42, 10.1128/iai.42.1.285-292.1983 · DOI · Paper page
  22. Carlson, 1985, Protection by Candida albicans of Staphylococcus aureus in the Establishment of Dual Infection in Mice, Infect Immun, 50, 10.1128/iai.50.3.655-659.1985 · DOI
  23. Peters, 2013, Candida albicans-Staphylococcus aureus Polymicrobial Peritonitis Modulates Host Innate Immunity, Infect Immun, 81, 10.1128/IAI.00265-13 · DOI · Paper page
  24. Allison, 2019, The Host Immune System Facilitates Disseminated Staphylococcus aureus Disease Due to Phagocytic Attraction to Candida albicans During Coinfection: A Case of Bait and Switch, Infect Immun, 87, 10.1128/IAI.00137-19 · DOI
  25. Bistoni, 1986, Evidence for Macrophage-Mediated Protection Against Lethal Candida albicans Infection, Infect Immun, 51, 10.1128/iai.51.2.668-674.1986 · DOI · Paper page
  26. Todd, 2019, Candida albicans Augments Staphylococcus aureus Virulence by Engaging the Staphylococcal Agr Quorum Sensing System, mBio, 10, 10.1128/mBio.00910-19 · DOI
  27. Wang, 2016, Regulation of Virulence in Staphylococcus aureus: Molecular Mechanisms and Remaining Puzzles, Cell Chem Biol, 23, 10.1016/j.chembiol.2016.01.004 · DOI · Paper page
  28. Regassa, 1992, Alkaline pH Decreases Expression of the Accessory Gene Regulator (Agr) in Staphylococcus aureus, J Bacteriol, 174, 10.1128/jb.174.15.5095-5100.1992 · doi:10.1128/jb.174.15.5095-5100.1992
  29. Regassa, 1992, Glucose and Nonmaintained pH Decrease Expression of the Accessory Gene Regulator (Agr) in Staphylococcus aureus, Infect Immun, 60, 10.1128/iai.60.8.3381-3388.1992 · DOI · Paper page
  30. Jenul, 2019, Regulation of Staphylococcus aureus Virulence, Microbiol Spectr, 7, 10.1128/microbiolspec.GPP3-0031-2018 · DOI · Paper page
  31. Todd, 2019, Candida albicans Impacts Staphylococcus aureus Alpha-Toxin Production via Extracellular Alkalinization, mSphere, 4, 10.1128/mSphere.00780-19 · DOI
  32. Nash, 2016, Morphology-Independent Virulence of Candida Species During Polymicrobial Intra-Abdominal Infections With Staphylococcus aureus, Infect Immun, 84, 10.1128/IAI.01059-15 · DOI
  33. Nash, 2014, Morphogenesis Is Not Required for Candida albicans-Staphylococcus aureus Intra-Abdominal Infection-Mediated Dissemination and Lethal Sepsis, Infect Immun, 82, 10.1128/IAI.01746-14 · DOI
  34. Doedt, 2004, APSES Proteins Regulate Morphogenesis and Metabolism in Candida albicans, Mol Biol Cell, 15, 10.1091/mbc.e03-11-0782 · DOI · Paper page
  35. Wang, 2014, Bacterial Peptidoglycan-Derived Molecules Activate Candida albicans Hyphal Growth, Commun Integr Biol, 1, 10.4161/cib.1.2.6870 · DOI
  36. Tan, 2021, A Peptidoglycan Storm Caused by β-Lactam Antibiotic’s Action on Host Microbiota Drives Candida albicans Infection, Nat Commun, 12, 2560, 10.1038/s41467-021-22845-2 · DOI
  37. Kong, 2010, Beta-Lactam Antibiotics: From Antibiosis to Resistance and Bacteriology, Apmis, 118, 1, 10.1111/j.1600-0463.2009.02563.x · DOI · Paper page
  38. Konopka, 2012, N-Acetylglucosamine Functions in Cell Signaling, Sci, 2012, 489208, 10.6064/2012/489208 · DOI · Paper page
  39. Park, 2008, How Bacteria Consume Their Own Exoskeletons (Turnover and Recycling of Cell Wall Peptidoglycan), Microbiol Mol Biol R, 72, 10.1128/MMBR.00027-07 · DOI · Paper page
  40. Alvarez, 2007, Identification of an N-Acetylglucosamine Transporter That Mediates Hyphal Induction in Candida albicans, Mol Biol Cell, 18, 10.1091/mbc.e06-10-0931 · DOI · Paper page
  41. Min, 2019, N-Acetylglucosamine Regulates Morphogenesis and Virulence Pathways in Fungi, J Fungi, 6, 8, 10.3390/jof6010008 · DOI · Paper page
  42. Naseem, 2011, N-Acetylglucosamine (GlcNAc) Induction of Hyphal Morphogenesis and Transcriptional Responses in Candida albicans Are Not Dependent on Its Metabolism, J Biol Chem, 286, 10.1074/jbc.M111.249854 · DOI · Paper page
  43. Naseem, 2015, Hyphal Growth in Candida albicans Does Not Require Induction of Hyphal-Specific Gene Expression, Mol Biol Cell, 26, 10.1091/mbc.E14-08-1312 · DOI · Paper page
  44. Vesely, 2017, N-Acetylglucosamine Metabolism Promotes Survival of Candida albicans in the Phagosome, mSsphere, 2, 10.1128/mSphere.00357-17 · DOI · Paper page
  45. Borisova, 2016, Peptidoglycan Recycling in Gram-Positive Bacteria Is Crucial for Survival in Stationary Phase, mBio, 7, 10.1128/mBio.00923-16 · DOI
  46. Finkel, 2011, Genetic Control of Candida albicans Biofilm Development, Nat Rev Microbiol, 9, 10.1038/nrmicro2475 · DOI · Paper page
  47. Moormeier, 2017, Staphylococcus aureus Biofilm: A Complex Developmental Organism, Mol Microbiol, 104, 10.1111/mmi.13634 · DOI · Paper page
  48. Harriott, 2009, Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial Resistance, Antimicrob Agents Ch, 53, 10.1128/AAC.00657-09 · DOI · Paper page
  49. Peters, 2010, Microbial Interactions and Differential Protein Expression in Staphylococcus aureus –Candida albicans Dual-Species Biofilms, FEMS Immunol Med Mic, 59, 493, 10.1111/j.1574-695X.2010.00710.x · DOI · Paper page
  50. Zago, 2015, Dynamics of Biofilm Formation and the Interaction Between Candida albicans and Methicillin-Susceptible (MSSA) and -Resistant Staphylococcus aureus (MRSA), PLoS One, 10, e0123206, 10.1371/journal.pone.0123206 · DOI · Paper page
  51. Peters, 2012, Staphylococcus aureus Adherence to Candida albicans Hyphae Is Mediated by the Hyphal Adhesin Als3p, Microbiology, 158, 10.1099/mic.0.062109-0 · DOI · Paper page
  52. Harriott, 2010, Ability of Candida albicans Mutants To Induce Staphylococcus aureus Vancomycin Resistance During Polymicrobial Biofilm Formation, Antimicrob Agents Ch, 54, 10.1128/AAC.00573-10 · DOI · Paper page
  53. Peters, 2013, Efficacy of Ethanol Against Candida albicans and Staphylococcus aureus Polymicrobial Biofilms, Antimicrob Agents Ch, 57, 74, 10.1128/AAC.01599-12 · DOI
  54. Krause, 2015, Prostaglandin E2 From Candida albicans Stimulates the Growth of Staphylococcus aureus in Mixed Biofilms, PLoS One, 10, e0135404, 10.1371/journal.pone.0135404 · DOI
  55. Kong, 2016, Commensal Protection of Staphylococcus aureus Against Antimicrobials by Candida albicans Biofilm Matrix, mBio, 7, 10.1128/mBio.01365-16 · DOI · Paper page
  56. Baillie, 2000, Matrix Polymers of Candida Biofilms and Their Possible Role in Biofilm Resistance to Antifungal Agents, J Antimicrob Chemoth, 46, 397, 10.1093/jac/46.3.397 · DOI · Paper page
  57. Boles, 2008, Agr-Mediated Dispersal of Staphylococcus aureus Biofilms, PLoS Pathog, 4, e1000052, 10.1371/journal.ppat.1000052 · DOI · Paper page
  58. Heim, 2020, Lactate Production by Staphylococcus aureus Biofilm Inhibits HDAC11 to Reprogramme the Host Immune Response During Persistent Infection, Nat Microbiol, 5, 10.1038/s41564-020-0756-3 · DOI · Paper page
  59. Ballou, 2016, Lactate Signalling Regulates Fungal β-Glucan Masking and Immune Evasion, Nat Microbiol, 2, 16238, 10.1038/nmicrobiol.2016.238 · DOI · Paper page
  60. Ramage, 2002, Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule, Appl Environ Microb, 68, 10.1128/AEM.68.11.5459-5463.2002 · DOI · Paper page
  61. Jabra-Rizk, 2006, Effect of Farnesol on Staphylococcus aureus Biofilm Formation and Antimicrobial Susceptibility, Antimicrob Agents Ch, 50, 10.1128/AAC.50.4.1463-1469.2006 · DOI · Paper page
  62. Kuroda, 2007, Sesquiterpene Farnesol as a Competitive Inhibitor of Lipase Activity of Staphylococcus aureus, FEMS Microbiol Lett, 273, 28, 10.1111/j.1574-6968.2007.00772.x · DOI
  63. Kong, 2017, Modulation of Staphylococcus aureus Response to Antimicrobials by the Candida albicans Quorum Sensing Molecule Farnesol, Antimicrob Agents Ch, 61, 10.1128/AAC.01573-17 · DOI
  64. Vila, 2019, Candida albicans Quorum-Sensing Molecule Farnesol Modulates Staphyloxanthin Production and Activates the Thiol-Based Oxidative-Stress Response in Staphylococcus aureus, Virulence, 10, 10.1080/21505594.2019.1635418 · DOI · Paper page
  65. Noverr, 2001, Pathogenic Yeasts Cryptococcus neoformans and Candida albicans Produce Immunomodulatory Prostaglandins, Infect Immun, 69, 10.1128/IAI.69.5.2957-2963.2001 · DOI · Paper page
  66. Lin, 2013, Interactions Between Candida albicans and Staphylococcus aureus Within Mixed Species Biofilms, Bios, 84, 10.1893/0005-3155-84.1.30 · DOI
  67. Liu, 2019, Characterization of the Mechanism and Impact of Staphylokinase on the Formation of Candida albicans and Staphylococcus aureus Polymicrobial Biofilms, J Med Microbiol, 68, 10.1099/jmm.0.000914 · DOI
  68. Rogiers, 2018, Anidulafungin Increases the Antibacterial Activity of Tigecycline in Polymicrobial Candida albicans/Staphylococcus aureus Biofilms on Intraperitoneally Implanted Foreign Bodies, J Antimicrob Chemoth, 73, 10.1093/jac/dky246 · DOI
  69. Luo, 2021, Targeting Candida albicans in Dual-Species Biofilms With Antifungal Treatment Reduces Staphylococcus aureus and MRSA In Vitro, PLoS One, 16, e0249547, 10.1371/journal.pone.0249547 · DOI
  70. Ceresa, 2021, Inhibitory Effects of Lipopeptides and Glycolipids on C. Albicans–Staphylococcus Spp. Dual-Species Biofilms, Front Microbiol, 11, 10.3389/fmicb.2020.545654 · DOI
  71. Tambone, 2021, Counter-Acting Candida albicans-Staphylococcus aureus Mixed Biofilm on Titanium Implants Using Microbial Biosurfactants, Polymers-basel, 13, 2420, 10.3390/polym13152420 · DOI
  72. Pammi, 2013, Biofilm Extracellular DNA Enhances Mixed Species Biofilms of Staphylococcus epidermidis and Candida albicans, BMC Microbiol, 13, 10.1186/1471-2180-13-257 · DOI · Paper page
  73. Sapaar, 2014, Effects of Extracellular DNA From Candida albicans and Pneumonia-Related Pathogens on Candida Biofilm Formation and Hyphal Transformation, J Appl Microbiol, 116, 10.1111/jam.12483 · DOI · Paper page
  74. Rani, 2007, Spatial Patterns of DNA Replication, Protein Synthesis, and Oxygen Concentration Within Bacterial Biofilms Reveal Diverse Physiological States, J Bacteriol, 189, 10.1128/JB.00107-07 · DOI · Paper page
  75. Chung, 2020, Hypoxia: A Double-Edged Sword During Fungal Pathogenesis, Front Microbiol, 11, 10.3389/fmicb.2020.01920 · DOI
  76. Stichternoth, 2009, Hypoxic Adaptation by Efg1 Regulates Biofilm Formation by Candida albicans, Appl Environ Microb, 75, 10.1128/AEM.00098-09 · DOI · Paper page
  77. McGovern, 2011, Hypoxia Selectively Inhibits Respiratory Burst Activity and Killing of Staphylococcus aureus in Human Neutrophils, J Immunol, 186, 10.4049/jimmunol.1002213 · DOI · Paper page
  78. Hajdamowicz, 2019, The Impact of Hypoxia on the Host-Pathogen Interaction Between Neutrophils and Staphylococcus aureus, Int J Mol Sci, 20, 5561, 10.3390/ijms20225561 · DOI
  79. Wilde, 2015, Bacterial Hypoxic Responses Revealed as Critical Determinants of the Host-Pathogen Outcome by TnSeq Analysis of Staphylococcus aureus Invasive Infection, PLoS Pathog, 11, e1005341, 10.1371/journal.ppat.1005341 · DOI · Paper page
  80. Adam, 2002, Mixed Species Biofilms of Candida albicans and Staphylococcus epidermidis, J Med Microbiol, 51, 10.1099/0022-1317-51-4-344 · DOI · Paper page
  81. El-Azizi, 2004, Interactions of Candida albicans With Other Candida Spp. And Bacteria in the Biofilms, J Appl Microbiol, 96, 10.1111/j.1365-2672.2004.02213.x · DOI · Paper page
  82. Kanangat, 2001, Enhanced Extracellular Growth of Staphylococcus aureus in the Presence of Selected Linear Peptide Fragments of Human Interleukin (IL)-1β and IL-1 Receptor Antagonist, J Infect Dis, 183, 10.1086/317645 · DOI
  83. Domenico, 2018, Inflammatory Cytokines and Biofilm Production Sustain Staphylococcus aureus Outgrowth and Persistence: A Pivotal Interplay in the Pathogenesis of Atopic Dermatitis, Sci Rep-uk, 8, 9573, 10.1038/s41598-018-27421-1 · DOI
  84. Schlecht, 2015, Systemic Staphylococcus aureus Infection Mediated by Candida albicans Hyphal Invasion of Mucosal Tissue, Microbiology+, 161, 10.1099/mic.0.083485-0 · DOI · Paper page
  85. Todd, 2019, Candida albicans and Staphylococcus aureus Pathogenicity and Polymicrobial Interactions: Lessons Beyond Koch’s Postulates, J Fungi, 5, 81, 10.3390/jof5030081 · DOI · Paper page
  86. Dyck, 2021, Adhesion of Staphylococcus aureus to Candida albicans During Co-Infection Promotes Bacterial Dissemination Through the Host Immune Response, Front Cell Infect Microbiol, 10, 10.3389/fcimb.2020.624839 · DOI · Paper page
  87. de Carvalho Dias, 2017, Soluble Factors From Biofilm of Candida albicans and Staphylococcus aureus Promote Cell Death and Inflammatory Response, BMC Microbiol, 17, 146, 10.1186/s12866-017-1031-5 · DOI
  88. Scherr, 2015, Staphylococcus aureus Biofilms Induce Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin, mBio, 6, 10.1128/mBio.01021-15 · DOI · Paper page
  89. Bernard, 2019, Candida albicans Interaction With Gram-Positive Bacteria Within Interkingdom Biofilms, J Mycol Médicale, 30, 100909, 10.1016/j.mycmed.2019.100909 · DOI
  90. Scheper, 2008, Farnesol, a Fungal Quorum-Sensing Molecule Triggers Apoptosis in Human Oral Squamous Carcinoma Cells, Neoplasia, 10, 10.1593/neo.08444 · DOI · Paper page
  91. Unnanuntana, 2009, The Effects of Farnesol on Staphylococcus aureus Biofilms and Osteoblasts, J Bone Jt Surg, 91, 10.2106/JBJS.H.01699 · DOI
  92. Lin, 2009, Th1-Th17 Cells Mediate Protective Adaptive Immunity Against Staphylococcus aureus and Candida albicans Infection in Mice, PLoS Pathog, 5, e1000703, 10.1371/journal.ppat.1000703 · DOI · Paper page
  93. Minegishi, 2007, Dominant-Negative Mutations in the DNA-Binding Domain of STAT3 Cause Hyper-IgE Syndrome, Nature, 448, 10.1038/nature06096 · DOI · Paper page
  94. Li, 2018, Mucocutaneous IL-17 Immunity in Mice and Humans: Host Defense vs. Excessive Inflammation, Mucosal Immunol, 11, 10.1038/mi.2017.97 · DOI · Paper page
  95. McLoughlin, 2006, CD4+ T Cells and CXC Chemokines Modulate the Pathogenesis of Staphylococcus aureus Wound Infections, Proc Natl Acad Sci, 103, 10.1073/pnas.0508961103 · DOI · Paper page
  96. Trautwein-Weidner, 2015, IL-17-Mediated Antifungal Defense in the Oral Mucosa Is Independent of Neutrophils, Mucosal Immunol, 8, 10.1038/mi.2014.57 · DOI
  97. Spellberg, 2008, The Antifungal Vaccine Derived From the Recombinant N Terminus of Als3p Protects Mice Against the Bacterium Staphylococcus aureus, Infect Immun, 76, 10.1128/IAI.00700-08 · DOI · Paper page
  98. Yeaman, 2014, Mechanisms of NDV-3 Vaccine Efficacy in MRSA Skin Versus Invasive Infection, Proc Natl Acad Sci, 111, 10.1073/pnas.1415610111 · DOI · Paper page
  99. Netea, 2011, Trained Immunity: A Memory for Innate Host Defense, Cell Host Microbe, 9, 10.1016/j.chom.2011.04.006 · DOI · Paper page
  100. Divangahi, 2021, Trained Immunity, Tolerance, Priming and Differentiation: Distinct Immunological Processes, Nat Immunol, 22, 2, 10.1038/s41590-020-00845-6 · DOI · Paper page
  101. Cheng, 2014, mTOR- and HIF-1α–Mediated Aerobic Glycolysis as Metabolic Basis for Trained Immunity, Science, 345, 1250684, 10.1126/science.1250684 · DOI · Paper page
  102. Luzio, 1978, Protective Effect of Glucan Against Systemic Staphylococcus aureus Septicemia in Normal and Leukemic Mice, Infect Immun, 20, 10.1128/iai.20.3.804-810.1978 · DOI · Paper page
  103. Cottier, 2019, Remasking of Candida albicans β-Glucan in Response to Environmental pH Is Regulated by Quorum Sensing, mBio, 10, 10.1128/mBio.02347-19 · DOI · Paper page
  104. Romero, 2011, The Toll-Like Receptor 4 Agonist Monophosphoryl Lipid A Augments Innate Host Resistance to Systemic Bacterial Infection, Infect Immun, 79, 10.1128/IAI.00022-11 · DOI
  105. Fensterheim, 2018, The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism, J Immunol, 200, ji1800085, 10.4049/jimmunol.1800085 · DOI
  106. Lilly, 2018, Immune Protection Against Lethal Fungal-Bacterial Intra-Abdominal Infections, mBio, 9, 10.1128/mBio.01472-17 · DOI
  107. Lilly, 2019, Spectrum of Trained Innate Immunity Induced by Low-Virulence Candida Species Against Lethal Polymicrobial Intra-Abdominal Infection, Infect Immun, 87, 10.1128/IAI.00348-19 · DOI
  108. Esher, 2019, Candida/Staphylococcal Polymicrobial Intra-Abdominal Infection: Pathogenesis and Perspectives for a Novel Form of Trained Innate Immunity, J Fungi, 5, 37, 10.3390/jof5020037 · DOI
  109. Chan, 2017, Innate Immune Memory Contributes to Host Defense Against Recurrent Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus, Infect Immun, 85, 10.1128/IAI.00876-16 · DOI · Paper page
  110. Chan, 2018, Protective Immunity in Recurrent Staphylococcus aureus Infection Reflects Localized Immune Signatures and Macrophage-Conferred Memory, Proc Natl Acad Sci, 115, 201808353, 10.1073/pnas.1808353115 · DOI · Paper page
  111. Kahl, 2016, Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections, Clin Microbiol Rev, 29, 10.1128/CMR.00069-15 · DOI · Paper page
  112. Lung, 2020, Staphylococcus aureus Small Colony Variants Impair Host Immunity by Activating Host Cell Glycolysis and Inducing Necroptosis, Nat Microbiol, 5, 10.1038/s41564-019-0597-0 · DOI · Paper page

Cited by

See all 67

Metadata

Authors
Eichelberger, K. R., & Cassat, J. E.
Venue
Frontiers in Immunology
Published
2021-12-08
Volume
12
ISSN
1664-3224
Cited by
67
References
25
Funders
National Institute of Allergy and Infectious Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic Adaptations During Staphylococcus aureus and Candida albicans Co-Infection. https://app.cochat.ai/papers/10.3389/fimmu.2021.797550
The paper
Eichelberger, K. R., & Cassat, J. E. (2021). Metabolic Adaptations During Staphylococcus aureus and Candida albicans Co-Infection. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.797550

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.